Amplification and Sequencing of the Hepatitis C Virus NS3/4A Protease and the NS5B Polymerase Regions for Genotypic Resistance Detection of Clinical Isolates of Subtypes 1a and 1b

Methods in Molecular Biology

Volumn 1030, Issue , 2013, Pages 137-149

  Koletzki, Diana ^a   Pattery, Theresa ^a   Fevery, Bart ^a   Vanhooren, Leen ^a   Stuyver, Lieven J ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Amplification; Genotyping; Hepatitis C virus (HCV); NS3 protease; NS3 4A protease; NS5B polymerase; Sanger sequencing

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 5B; RNA POLYMERASE; VIRUS RNA;

AGAR GEL ELECTROPHORESIS; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC RESISTANCE; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS;

CELL LINE; DRUG RESISTANCE, VIRAL; GENOTYPE; HEPACIVIRUS; HUMANS; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84880128003     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-484-5_12     Document Type: Article

References (7)

1. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345(1):41-52
2. Choo QL et al (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244(4902):359-362
3. Simmonds P et al (2005) Consensus proposals for a unifi ed system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4): 962-973
4. Kuiken C, Simmonds P (2009) Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 510:33-53
5. Simmonds P (2001) The origin and evolution of hepatitis viruses in humans. J Gen Virol 82(Pt 4):693-712
6. Kwong AD et al (2011) Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recom mendations from the HCV DRAG. Gastroenterology 140: 755-760
7. HCV Phenotype Working Group, HCV Drug Development Advisory Group (2012) Clinically relevant HCV drug resistance mutations fi gures and tables. Ann Forum Collab HIV Res 14(2): 1-10